Industry News
VCs to run new $107m pre-seed plan
Large venture capital entities have snared all four of the licences to manage the Federal government's new $107 million plan to fill the pre-seed funding gap facing promising technologies. [ + ]
Vets urge caution on pet cloning
A session on the ethics of pet cloning and genetic modification at this week's Australian Veterinary Association conference in Adelaide heard that people needed to feel comfortable with cloning before they would buy it. [ + ]
CSL slide continues despite 'buy' status
Investors continued to punish biotech big gun CSL today, despite analysts recommending the stock as a definite buy. [ + ]
Cryosite makes ASX debut
Australia's first for-profit tissue banking service company, Cryosite, listed on the ASX today (May 9). [ + ]
Mass spec diagnostic developed for ovarian cancer
Mass spectrometry is helping Melbourne researchers develop a diagnostic test for the early detection of ovarian cancer. [ + ]
HIPAA compliance: the clock is ticking
With the first deadline to implement new medical record regulations less than a year away, bioscience companies should be taking a hard look at whether these complicated US federal mandates will affect them. [ + ]
Bionomics in licensing deal with J&J
South Australian genomics research company Bionomics (ASX: BNO) has entered a licensing deal with Johnson & Johnson Research (JJR) to develop angiogenesis drugs. [ + ]
Public invited to have a say on GM cotton
The Australia and New Zealand Food Authority (ANZFA) has invited public comment on its proposal to approve the use of a new version of Monsanto's genetically modified Bt-Cotton. [ + ]
Neural stem cell research could bring Parkinson's cure closer
Melbourne scientists have become the first in Australia to culture adult neural stem cells, bringing local medicine a step closer to a potential cure for Parkinson's disease. [ + ]
MBAs told to go offshore for biotech experience
Business management students were told yesterday that they may have to work overseas before they sought employment in Australia's biotechnology industry. [ + ]
Agenix revenue record
Public concern over deep vein thrombosis has helped boost revenues of listed biotech Agenix to a record $29 million in the nine months to March 31. [ + ]
Skin cancer device launched
A device for the early detection of skin cancer has been launched by Sydney-based medical device company, Polartechnics. [ + ]
Research consortium seeks government support
A consortium of eight research groups is pitching for Victorian Government support in a bid to become Australia's first fee-for-service pharmaceutical pipeline group. [ + ]
Vic Budget brings in the bucks for biotech
Victoria's government has unveiled a cash injection of $68.7 million for biotechnology and commercialisation, including a doubling in funding for medical research infrastructure in a bid to lure top scientists back to the state. [ + ]
With deal closed, countdown to new HP begins
With the legal closing on Friday May 3 of its Compaq acquisition, and a turbulent nine months behind it, Hewlett-Packard is at last poised to commence merged operations. [ + ]